Д-р Ави Бери Сураски медициналық орталығында простата процедураларына, соның ішінде простатаны трансуретральды резекциялауға (ТУРП) маманданған.
42 жылдар астам хирургиялық тәжірибесі бар доктор Джозеф Клаузнер колоректальды, ұйқы безі және асқазан-ішек жолдары процедураларына маманданған.
Д-р Хьюз Хюн аз инвазивті және роботтандырылған хирургияға маманданған, бұл пациенттердің тезірек сауығуына көмектеседі.
Доктор Зенгин урология саласында _doctor_8416_ жылдан астам тәжірибеге ие және қазіргі уақытта Lokman Hekim Akay ауруханасында қызмет атқарады.
Доктор Джордж Тай Ponderas академиялық ауруханасында простатаға жасалатын аз инвазивті операцияларға, соның ішінде ТУИП-ке маманданған.
Доцент Озкан Онук Medical Park Bahcelievler ауруханасында урологиялық процедураларға маманданған және қуық асты безін емдеу бойынша ауқымды зерттеулер жүргізеді.
Д-р Мұстафа Серкан Алемдар Medical Park Antalya аурухана кешенінде TUIP процедураларына маманданған, урологиялық араласулар бойынша үлкен тәжірибесі бар.
Нью-Йорктегі Memorial Sloan-Kettering онкологиялық орталығында білім алған доктор Наварро Вильчес Quirónsalud Marbella клиникасында урологиялық оталардың озық түрлеріне маманданған.
Профессор, доктор Кадир Онем — профессор урологии в больнице Medical Park в Самсуне. Он получил степень доктора медицины и прошел ординатуру по урологии в Стамбульском университете. Затем он завершил постдокторскую стажировку в Медицинском колледже Бейлора (Baylor College of Medicine) в области нейроурологии, реконструктивной урологии и урологической онкологии. Он занимается лечением сложных нейроурологических и реконструктивных случаев у взрослых и детей. Им были разработаны хирургические методы лечения.
Он является главным исследователем в нескольких международных клинических испытаниях III–IV фазы, посвященных нейрогенному мочевому пузырю и раку мочевого пузыря. На его счету более 70 публикаций и глав в книгах. Он выступает в качестве рецензента для ряда научных журналов.
Руководство и членство в организациях: Президент Турецкой урологической ассоциации — отделение Западного Причерноморья (2025 г.). Комитет по профилактике ISCoS (2025 г.). Группа по нейроурологии EAU (2023–2025 гг.). Комитет по нейроурологии ICS (2023–2025 гг.). Совет INUS (2023 г.). Награды: TUA (2016, 2017, 2020, 2022 гг.) и ICS (2020 г.).
Büyük Anadolu ауруханаларында ашық және жабық простата операцияларын қоса алғанда, урологиялық процедураларға маманданған.
Д-р Яаков Лоуренс — «Шиба» медициналық орталығының радиациялық онкология бөлімінің меңгерушісі. Ол прецизиялық сәулелік терапия және нейроонкология саласына маманданған. Д-р Лоуренс ұйқы безі обыры кезіндегі ауырсынуды басу үшін құрсақ жүйке өрімінің радиохирургиясы саласында пионер болды. Ол өз мамандығы бойынша ең жоғары марапаттардың бірі — FASTRO атағына ие.
Д-р Дорит Зильберман — Израильдегі «Шиба» медициналық орталығының жетекші урологы. Ол роботтандырылған және аз инвазивті урологиялық хирургия саласындағы пионер болып табылады. Д-р Зильберман бүйрек, қуық және қуықасты безінің қатерлі ісігін емдейді. Ол «Шибада» da Vinci роботтандырылған хирургия бағдарламасын іске қосуға көмектесті. Forbes Israel оны елдегі ең үздік дәрігерлердің қатарына қосты.
Доцент Джем Басатак Gayrettepe Florence Nightingale ауруханасында лапароскопиялық хирургияға баса назар аудара отырып, урология саласында маманданған.
Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.
1980–1985: Completed doctoral studies at Nagasaki University, Japan
1968–present: Department of Radiology, Chinese PLA General Hospital
1988: Third Prize of the Military Science and Technology Progress Award
1989–present: Member of Radiological Society of North America(RSNA)
1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA
1991: Second Prize of the Military Science and Technology Progress Award
1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology
1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology
1993: Granted the Lifetime Special Government Allowance of the State Council
1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology
1994: Third Prize of the Military Science and Technology Progress Award
1997: Second Prize of the Military Science and Technology Progress Award
1997–2009: Standing Member of Chinese Society of Radiology
1999: Third Prize of the Military Science and Technology Progress Award
1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology
2002: Second Prize of the Military Science and Technology Progress Award
2005: Third Prize of the Military Science and Technology Progress Award
Member of Radiological Society of North America(RSNA)
Standing Member of Chinese Society of Radiology
Group Leader of the Group of Intervention of Chinese Journal of Radiology
Deputy Director Member of Chinese Society of Interventional Oncology
Director Member of Beijing Medical Association Society of Interventional Radiology
Deputy Chief Editor of Chinese Journal of Medical Image Technology
Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army
Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology
Awarded the Special Government Allowance of the State Council
Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.
Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”
Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.
In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.
Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.
In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.
Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.
From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.
Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.
1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.
Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.
2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.
Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.
3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.
Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.
4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.
Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.
5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.
Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.
6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.
Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.
7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.
Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.
8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.
Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.
1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.
2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.
3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.
1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.
2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.
3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.
4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.
Дәрігер — 2017 жылдан бері Hospital Quirónsalud Torrevieja ауруханасының урология бөлімінің меңгерушісі қызметін атқарып келе жатқан жоғары білікті уролог маман. Германиядағы Иоганн Гутенберг университетінде медициналық білім мен мамандану алған дәрігер 2007 жылдан бері келе жатқан мол клиникалық тәжірибеге ие. Дәрігердің сараптамалық бағыттарына онкоурология, қуық асты безінің аурулары және несеп шығару жолдарының күрделі патологиялары жатады.
Дәрігер тәжірибесінің негізгі бағыты — роботтандырылған урологиялық хирургия, атап айтқанда, қуық асты безінің қатерлі ісігіне операция жасау кезінде Da Vinci хирургиялық жүйесін қолдану. Дәрігер «Differentialdiagnose Urologie» кітабының тарауларын қоса алғанда, академиялық әдебиеттерге үлес қосқан және жергілікті, сондай-ақ халықаралық пациенттерге жоғары сапалы медициналық көмек көрсетуге баса назар аударады.
Доктор Озкан Büyük Anadolu ауруханаларында ТУИП әдісімен қуықасты безі ауруларын емдеуге маманданған.
Büyük Anadolu ауруханаларында RIRS және ашық/жабық простата операцияларына, соның ішінде TUIP-ке маманданған.
Д-р Даниэль Лещинский урология саласында _doctor_9996_ жылдық тәжірибеге ие, Carolina Hospital ауруханасында ТУИП сияқты аз инвазивті процедураларға маманданған.
2500-ден астам простатаның фьюжн-биопсиясын жасаған – доктор Чарнецки Carolina Hospital-да роботтандырылған терапия және фокалды емдеу бойынша маманданған.
Дәрігер – үш онжылдықтан астам уақытты қамтитын бай тәжірибесі бар жоғары білікті уролог-маман. 1988 жылы Улудаг университетінің медицина факультетін бітіргеннен кейін, дәрігер 1997 жылы урология бойынша мамандандыру бағдарламасын аяқтады. 2006 жылы дәрігер доцент атағын, ал 2011 жылы профессор атағын алды.
Өзінің көрнекті мансабында дәрігер көптеген басшылық қызметтерді атқарды, соның ішінде бірнеше университет ауруханаларында урология бөлімінің меңгерушісі болды және ірі оқу-зерттеу ауруханаларында білім беру және әкімшілік жетекшісі ретінде қызмет етті. Дәрігер клиникалық урология саласында терең білімге ие және Түркияның әртүрлі мемлекеттік және жеке медициналық мекемелерінде жұмыс істеген.